BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced the positive outcome of the DELTA 3 trial. DELTA 3 is a phase 3, single-arm, open-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results